flurbiprofen has been researched along with butylscopolammonium bromide in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Allende Honorato, L; Artigas Raventós, V; Camp Herrero, J; Domínguez Granados, R; Millá Santos, J; Moreno Carretero, E | 1 |
Arrizabalaga Moreno, M; Camp Herrero, J; del Nogal Saez, F; Domínguez Granados, R; Extramiana Cameno, J; Gimeno Albo, F; Milla Santos, J; Mora Durban, MJ; Moreno Carretero, E; Paniagua Andrés, P | 1 |
2 trial(s) available for flurbiprofen and butylscopolammonium bromide
Article | Year |
---|---|
[The efficacy of injectable flurbiprofen in the symptomatic treatment of biliary colic].
Topics: Adult; Aged; Aged, 80 and over; Biliary Tract Diseases; Butylscopolammonium Bromide; Cholelithiasis; Clinical Trials as Topic; Colic; Double-Blind Method; Female; Flurbiprofen; Humans; Injections, Intramuscular; Male; Middle Aged; Pentazocine | 1992 |
[Flubiprofen vs dipyrone combined with hyoscine: the analgesic efficacy in renal colic].
Topics: Adolescent; Adult; Aged; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Butylscopolammonium Bromide; Chi-Square Distribution; Colic; Dipyrone; Double-Blind Method; Drug Therapy, Combination; Female; Flurbiprofen; Humans; Kidney Diseases; Male; Middle Aged; Scopolamine | 1995 |
2 other study(ies) available for flurbiprofen and butylscopolammonium bromide
Article | Year |
---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |